Browsing bySubjectCRIZOTINIB

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 5 of 5

Issue DateTitleAuthor(s)
2016-12Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung CancerBahcall, Magda; Sim, Taebo; Paweletz, Cloud P.; Patel, Jyoti D.; Alden, Ryan S.; Kuang, Yanan; Sacher, Adrian G.; Kim, Nam Doo; Lydon, Christine A.; Awad, Mark M.; Jaklitsch, Michael T.; Sholl, Lynette M.; Jaenne, Pasi A.; Oxnard, Geoffrey R.
2015-12-10Discovery of Inhibitors That Overcome the G1202R Anaplastic Lymphoma Kinase Resistance MutationHatcher, John M.; Bahcall, Magda; Choi, Hwan Geun; Gao, Yang; Sim, Taebo; George, Rani; Jaenne, Pasi A.; Gray, Nathanael S.
2015-01Optimization of Bipyridinyl Pyrazole Scaffolds via Design, Synthesis and Screening of a New Series of ROS1 Kinase-modulating CompoundsAl-Sanea, Mohammad M.; Park, Byung Sun; Abdelazem, Ahmed Z.; Selim, Khalid B.; Yoo, Kyung Ho; Sim, Taebo; Tae, Jin Sung; Lee, So Ha
2014-12-19Patient-derived models of acquired resistance can identify effective drug combinations for cancerCrystal, Adam S.; Shaw, Alice T.; Sequist, Lecia V.; Friboulet, Luc; Niederst, Matthew J.; Lockerman, Elizabeth L.; Frias, Rosa L.; Gainor, Justin F.; Amzallag, Arnaud; Greninger, Patricia; Lee, Dana; Kalsy, Anuj; Gomez-Caraballo, Maria; Elamine, Leila; Howe, Emily; Hur, Wooyoung; Lifshits, Eugene; Robinson, Hayley E.; Katayama, Ryohei; Faber, Anthony C.; Awad, Mark M.; Ramaswamy, Sridhar; Mino-Kenudson, Mari; Iafrate, A. John; Benes, Cyril H.; Engelman, Jeffrey A.
2014-08-01Structure-based optimization and biological evaluation of trisubstituted pyrazole as a core structure of potent ROS1 kinase inhibitorsPark, Byung Sun; Al-Sanea, Mohammad M.; Abdelazem, Ahmed Z.; Park, Hye Mi; Roh, Eun Joo; Park, Hyun-Mee; Yoo, Kyung Ho; Sim, Taebo; Tae, Jin Sung; Lee, So Ha

BROWSE